Glyphosate, 700,000 tons in manufacturing capacity was established at the end of 2008, including a lot of non-mainstream enterprises with small capacity, non-advanced manufacturing flow together with high pollution in environment.
Two years later, in 2011, those enterprises as above were almost closed, the rest are capable enough to face the high competitive international marketing.
Acetochlor, 128,000 tons is the manufacturing capacity in China in 2010, including 70,000 tons in domestic and 40,000 tons for export. It is a product with stable demand and supply.
Paraquat, 140,000 tons is the manufacturing capacity in China in 2010. Along with the additional capacity in tech and inte
rmediates for Paraquat in 2011, the cost will be decreased as estimated and the price will be decreased too.
Abamectin, from 1995 to 2009, the annual growth in demand was average 50%. But in 2010, compare with 2009, the growth rate in demand is 3%. It can be recognized as the demand growth stagnation. What’s happened on this product should be considered seriously. The capacity of Abamectin will be 5,000 tons in China in 2011.
Imidacloprid, the capacity is 26,500 tons per year now with stable demand and supply.
Chlorpyrifos has the most serious overcapacity. 120,000 tons in capacity compare with 30,000 tons in demand. It always faces the research in forbidden use at several countries make situation a more serous one.
Carbendazim, 26,000 in producing capacity while more than 20,000 in demand. The balance will be broken if additional capacity appears.
Mancozeb, six manufacturers total 52,000 tons in capacity, four manufacturers are producing so that the actual capacity is 38,000 tons in 2010. While 60,000 tons in India average on three manufacturers, another 15,000 tons are from DOW for the use of itself. The total demand was 800,000 to 100,000 in 2010 were covered by the manufacturers from China and India.
From: www. ccpia. org. cn
By Jane |